Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection
- 29 January 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (5), 1082-1089
- https://doi.org/10.1016/j.vaccine.2010.11.063
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P50 CA098252, P50 CA96784-06)
This publication has 38 references indexed in Scilit:
- The combination of TLR‐9 adjuvantation and electroporation‐mediated delivery enhances in vivo antitumor responses after vaccination with HPV‐16 E7 encoding DNAInternational Journal of Cancer, 2010
- Optimised electroporation mediated DNA vaccination for treatment of prostate cancerGenetic Vaccines and Therapy, 2010
- Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNAGene Therapy, 2009
- Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun deliveryVaccine, 2009
- Therapeutic human papillomavirus vaccines: current clinical trials and future directionsExpert Opinion on Biological Therapy, 2008
- Monitoring the Trafficking of Adoptively Transferred Antigen- Specific CD8-Positive T Cells In Vivo, Using Noninvasive Luminescence ImagingHuman Gene Therapy, 2007
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boostVaccine, 2007
- Epigallocatechin-3-Gallate Enhances CD8+ T Cell–Mediated Antitumor Immunity Induced by DNA VaccinationCancer Research, 2007
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004